As the first plasma treatment ever produced, this plasma-derived medicine was created to replace lost blood volume and essential blood proteins following trauma, shock and severe burns. Albumin is also the name of a naturally occurring protein found in plasma. Alpha-1-antitrypsin deficiency

Also referred to as a new donor, this is someone who has donated one time or returned for a second donation but whose plasma test results haven't been received yet. Center manager

A machine that separates contents of various densities, such as plasma from blood, by spinning at such a high speed that the matter with the highest density is forced away from the center. Chronic inflammatory demyelinating polyneuropathy (CIDP)

A condition in which there is an increased tendency for excessive blood clotting, often repeated and over an extended period of time. Current Good Manufacturing Practices (cGMP)

A prospective donor who has been disqualified from donating plasma, either temporarily or permanently. Donor Doc®

A Grifols plasma donation center team member who greets donors and confirms that they have the required documentation, assists donors with their initial paperwork and begins the initial health screening. Donor referral bonus

The European Medicines Agency is responsible for the protection and promotion of public and animal health through the evaluation and supervision of medicines for human and veterinary use. Many of our plasma donor centers are inspected and licensed by the EMA. Factor VIII

The United States Department of Food and Drug Administration is an agency within the Department of Health and Human Services that oversees the core functions of Medical Products and Tobacco, Foods, Global Regulatory Operations and Policy, and Operations. All Grifols plasma donation centers are inspected and licensed by the FDA. Fractionation

A condition caused by an alpha-1-antitrypsin deficiency where the small air sacs in the lungs are damaged resulting in a hacking cough and difficulty breathing. Hematocrit

A bleeding disorder in which a clotting factor protein, such as factor VIII or IX, is completely or partially lacking or doesn't function normally. Idiopathic thrombocytopenic purpura (ITP)